2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow Chronic Hepatitis B: new trials by email Literature Review of Chronic Hepatitis B trials Research Report on Chronic Hepatitis B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B telbivudine, adefovir dipivoxil - Chronic Hepatitis B | Phase 4 | Withdrawn | Novartis | 2007-11-01 | 2012-05-02 | |
| Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy Telbivudine, Adefovir, Tenofovir - Chronic Hepatitis B | Phase 4 | Withdrawn | Novartis Pharmaceuticals | 2015-03-09 |
Blood-Borne Infections (2) · Chronic Disease (2) · Communicable Diseases (2) · DNA Virus Infections (2) · Digestive System Diseases (2) · Disease Attributes (2) · Hepadnaviridae Infections (2) · Hepatitis (2) · Hepatitis B (2) · Hepatitis, Chronic (2) · Hepatitis, Viral, Human (2) · Infections (2) · Liver Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Telbivudine (2) · Tenofovir (1) · adefovir (1) · adefovir dipivoxil (1)
Novartis (1) · Novartis Pharmaceuticals (1)
United States (1)